Movano health receives fda clearance for eviemed ring

Company's first 510(k) clearance unlocks a tam of $40 billion in healthcare b2b opportunities pleasanton, calif. , dec. 2, 2024 /prnewswire/ -- movano health  (nasdaq: move), a pioneer in health technology, today announced u.s. food and drug administration (fda) 510(k) clearance for the pulse oximeter in its eviemed ring.
MOVE Ratings Summary
MOVE Quant Ranking